Literature DB >> 2026352

The epidemiology of endometrial cancer.

F Parazzini1, C La Vecchia, L Bocciolone, S Franceschi.   

Abstract

The descriptive and analytical epidemiology of endometrial cancer is reviewed. Over the last few decades, age-standardized incidence rates have been rising in several countries. The rise has been even greater in terms of absolute numbers of cases, and hence public health implications, due to the aging of the population. Although endometrial cancer rates were found to be higher in richer countries and urban populations, there is now evidence of some changes in the socioeconomic determinants of the disease in developed countries. In etiological terms, any factor that increases exposure to unopposed estrogens (such as menopausal replacement treatment, obesity, and irregular menstrual cycles) tends to increase the risk of the disease, while factors that decrease exposure to estrogens or increase progesterone levels (such as oral contraceptives or smoking) tend to be protective. Less well defined, or more difficult to explain in biological terms, is the role of other factors, such as births, miscarriages, or diabetes and hypertension, and only suggestive evidence is available on diet from analytical epidemiology. The data reviewed herein are discussed in terms of models of carcinogenesis, as well as attributable risks and public health implications.

Entities:  

Mesh:

Year:  1991        PMID: 2026352     DOI: 10.1016/0090-8258(91)90246-2

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  59 in total

1.  Pten, a protean tumor suppressor.

Authors:  G L Mutter
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

2.  Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer.

Authors:  Nicolas M Monte; Kaitlyn A Webster; Donna Neuberg; Gregory R Dressler; George L Mutter
Journal:  Cancer Res       Date:  2010-07-14       Impact factor: 12.701

Review 3.  Nutrition and endometrial cancer.

Authors:  H A Hill; H Austin
Journal:  Cancer Causes Control       Date:  1996-01       Impact factor: 2.506

4.  Harvard report on cancer prevention. Causes of human cancer. Reproductive factors.

Authors: 
Journal:  Cancer Causes Control       Date:  1996-11       Impact factor: 2.506

Review 5.  Management of endometrial precancers.

Authors:  Cornelia L Trimble; Michael Method; Mario Leitao; Karen Lu; Olga Ioffe; Moss Hampton; Robert Higgins; Richard Zaino; George L Mutter
Journal:  Obstet Gynecol       Date:  2012-11       Impact factor: 7.661

6.  Interleukin-11 in endometrial adenocarcinoma is regulated by prostaglandin F2alpha-F-prostanoid receptor interaction via the calcium-calcineurin-nuclear factor of activated T cells pathway and negatively regulated by the regulator of calcineurin-1.

Authors:  Kurt J Sales; Vivien Grant; Ian H Cook; David Maldonado-Pérez; Richard A Anderson; Alistair R W Williams; Henry N Jabbour
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

7.  Effect of tumor necrosis factor-alpha on estrogen metabolism and endometrial cells: potential physiological and pathological relevance.

Authors:  Salama A Salama; Marwa W Kamel; Concepcion R Diaz-Arrastia; Xia Xu; Timothy D Veenstra; Sana Salih; Shaleen K Botting; Raj Kumar
Journal:  J Clin Endocrinol Metab       Date:  2008-10-28       Impact factor: 5.958

8.  A 50% higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic status.

Authors:  W J Louwman; M J Aarts; S Houterman; F J van Lenthe; J W W Coebergh; M L G Janssen-Heijnen
Journal:  Br J Cancer       Date:  2010-10-26       Impact factor: 7.640

9.  Prostaglandin F(2alpha)-F-prostanoid receptor regulates CXCL8 expression in endometrial adenocarcinoma cells via the calcium-calcineurin-NFAT pathway.

Authors:  Kurt J Sales; David Maldonado-Pérez; Vivien Grant; Rob D Catalano; Martin R Wilson; Pamela Brown; Alistair R W Williams; Richard A Anderson; E Aubrey Thompson; Henry N Jabbour
Journal:  Biochim Biophys Acta       Date:  2009-10-09

10.  Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway.

Authors:  Peixin Dong; Zhujie Xu; Nan Jia; Dajin Li; Youji Feng
Journal:  Mol Cancer       Date:  2009-11-16       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.